Patent details

LUC00327 Product Name: cédazuridine ou un de ses sels pharmaceutiquement acceptables

Basic Information

Publication number:
LUC00327
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP088406335
Legal Status:
Inactive
Application number:
LUC00327
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/23/1756
Marketing Authorization Type:
Marketing Authorization Date:
18/09/2023
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
27/12/2023
First Marketing Authorization date:
18/09/2023
Grant date:
02/02/2026
Activation date:
Publication date:
27/12/2023
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
16/10/2033
SPC Extension Expiration:
16/10/2033
Rejection date:
Withdrawal date:

Owner

From:
27/12/2023
 
 

Name:
OTSUKA PHARMACEUTICAL CO., LTD.
Address:
2-9, KANDA TSUKASA-MACHI ,, CHIYODA-KU, TOKYO 101-8535, Japan (JP)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
27/12/2023
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2024/01
Publication date:
05/01/2024
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2026/04
Publication date:
03/03/2026
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
31/10/2028
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
27/12/2023 MA publication 10
27/12/2023 Application Form 3
27/12/2023 Marketing authorization 3
27/12/2023 General Document 3
27/12/2023 General Document 4
27/12/2023 Summary of the product caracteristics 36
27/12/2023 Outgoing Correspondence 1
27/12/2023 Publication 1
02/02/2026 Publication 1
02/02/2026 Certificate 1
02/02/2026 Outgoing Correspondence 1